Navigation Links
Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
Date:8/7/2008

RALEIGH, N.C., Aug. 7 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Darius Naigamwalla has been appointed Senior Vice President and head of the firm's Brand Management Practice. Mr. Naigamwalla replaces Nader Naeymi-Rad, who was recently promoted to Chief Operating Officer at the firm.

Mr. Naigamwalla has been a member of the Brand Management Practice since joining the firm in 2001. Since that time, he has worked across all service areas of the Brand Management Practice, from new product planning and market forecasting to commercial strategy development and launch excellence. Mr. Naigamwalla has helped dozens of companies in the United States, Canada, the United Kingdom, and Europe develop comprehensive commercial launch strategies across a range of therapeutic areas including cardiology, pulmonology, rheumatology, orthopedics, virology, hematology, hepatology, gastroenterology, critical care, nephrology, oncology, and endocrinology.

In his new role as the head of the Brand Management Practice, Mr. Naigamwalla will oversee the practice's complete operations in North America, the United Kingdom, and Europe.

"Darius is one of the most focused and disciplined individuals I've worked with over the span of my career in the pharmaceutical and biotech industry. Since his first year at Campbell Alliance, Darius has always been one of our most commonly requested consultants. He has developed and maintained an exceptional track record of client satisfaction-one of the founding principles and key success factors for the growth of Campbell Alliance overall. Regardless of the task at hand, Darius has consistently overcome significant obstacles to help meet the needs of our clients," stated John Campbell, CEO of Campbell Alliance.

Mr. Naigamwalla holds an MBA from the University of Victoria, an MS in biochemistry and molecular biology from t
'/>"/>

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc.
2. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
3. Lillys Connelly Appointed to the Presidents Commission on White House Fellowships
4. Graham Hetherington Appointed Chief Financial Officer and Board Director at Shire
5. James T. Glover Appointed to Board of Directors of Varian, Inc.
6. Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics
7. Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
8. Danong Chen appointed CEO of Theranostics Health
9. eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
10. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
11. Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Clear Lake, MN (PRWEB) May 21, 2013 ... all-in-one trade show display solution for sales and marketing teams ... GLM Displays describes the kit as “everything you’ll need ... The Fusion Fabric Display Kit comes with a number of ... an all-around trade booth 20 feet by 20 feet in ...
(Date:5/20/2013)... , Collaboration with the ... in treatment of mastitis , ... to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will collaborate ... Service (ARS) to develop and trial products targeting the ...
(Date:5/20/2013)... Oven Industries Inc. announces a new laboratory ... controller has many outstanding user-friendly benefits. Contained all in ... wall as a self-contained temperature control system, which has ... device unique, as well as highly convenient for users. ... be used universally, which allows the user to use ...
(Date:5/20/2013)... , May 20, 2013 Today, at ... San Francisco , James McGough ... Psychiatry at the Semel Institute for Neuroscience and Human ... of Medicine at the University of California Los Angeles ... Child and Adolescent Psychopharmacology and ADHD at UCLA, presented ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5
... EDMONTON , May 11 ... biotechnology company focused on developing medical device,products for ... that it has,received regulatory concurrence from the United ... lead product, Occlusin(R) 500 Artificial,Embolization Device (OCL 500) ...
... Cumberland Pharmaceuticals Inc. ( CPIX) and Phebra Pty ... granted regulatory approval for marketing and sale in Australia . Acetadote, ... the Therapeutic Goods Administration (TGA), the government agency responsible for regulating drugs ... , , ...
... N.J. , May 11 Scientists from Zymes LLC, ... the National Research Council of Canada presented ... California on April 28th .  The paper entitled, " ... induced rat model of Parkinson,s disease: The role of neurotrophic factors," ...
Cached Biology Technology:IMBiotechnologies Receives FDA Clearance to Market Occlusin(R) 500 Biodegradable Microspheres in the U.S. 2IMBiotechnologies Receives FDA Clearance to Market Occlusin(R) 500 Biodegradable Microspheres in the U.S. 3Acetadote(R) Approved in Australia for Treatment of Acetaminophen Poisoning 2Acetadote(R) Approved in Australia for Treatment of Acetaminophen Poisoning 3Acetadote(R) Approved in Australia for Treatment of Acetaminophen Poisoning 4Acetadote(R) Approved in Australia for Treatment of Acetaminophen Poisoning 5Zymes LLC, University of Windsor and National Research Council of Canada Collaborative Research Presented at the 2010 Experimental Biology Meeting in Anaheim, California 2
(Date:5/20/2013)... antibiotic colistin are also commonly resistant to antimicrobial ... a study in mBio , the online ... Cross-resistance to colistin and host antimicrobials LL-37 and ... attack, could mean that patients with life-threatening multi-drug ... immune response. Colistin is a last-line drug for ...
(Date:5/20/2013)... effect of physical education (PE) on child weight, but ... the amount of time that elementary schoolchildren spent in ... study represents some of the first evidence of a ... forthcoming in the Journal of Health Economics . ... be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The research ...
(Date:5/20/2013)... COLUMBUS, Ohio New research suggests that a compound ... "superpower" to escape death. , By altering a ... re-educates cancer cells into normal cells that die as ... by inhibiting a process that would cause them to ... strict programming. This study in cells, led by Ohio ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3Gym class reduces probability of obesity, study finds for first time 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
... 26 SVOX, the leading provider of,embedded speech ... Processing Group of Siemens AG, according to SVOX ... IP of Siemens AG developed,over 25 years, including ... 60 patent families. The majority of the Professional,Speech ...
... Researchers have reported the first clinical evidence that ... an important milestone for this promising treatment which has ... issue of the journal Human Gene Therapy ... with severe rheumatoid arthritis conducted in Germany and led ...
... scientists celebrate 2009 as the bicentennial of Charles Darwin,s ... will gather at the University of Utah Feb. 25-27 ... violence, from war to domestic abuse and homicide. ... we use this knowledge to promote a more peaceful ...
Cached Biology News:SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog 2Gene therapy demonstrates benefit in patients with rheumatoid arthritis 2Gene therapy demonstrates benefit in patients with rheumatoid arthritis 3The Evolution of Human Aggression: Feb. 25-27 conference 2The Evolution of Human Aggression: Feb. 25-27 conference 3The Evolution of Human Aggression: Feb. 25-27 conference 4
50 assays. Provides an easy system for rapid separation of cytosol and particulate fractions that are compatiable with downstream studies....
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
... 400 Spun Columns, 10. *SizeSep 400 Spun ... 400 base pairs in length. - ... and pre-equilibrated in distilled water containing 0.15% Kathon ... ~ 400 base pairs. *Extremely useful ...
... GFX Purification Kit, 25 purifications. ... cDNA probesProvides efficient removal of unincorporated ... reactions with superior yields of labeled ... purification of cDNA labeled by either ...
Biology Products: